Good day, ladies and gentlemen, and welcome to LivaNova plc Third Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded. I'd now like to ...
Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need ...
News-Medical.Net on MSN
New genomic method unlocks hidden diversity in ocean microbes and viruses
A new method vastly improves on the existing approach for single-cell genetic sequencing, enabling scientists to read the ...
Planned U.S. launch of Anaphylm™ in the first quarter of 2026, if approved by the FDA Advanced Anaphylm regulatory activities in Canada and the ...
According to DataM Intelligence, the Self-Sovereign Identity (SSI) Market Size is growing from USD 1.30 billion in 2024 to USD 44.98 billion by 2032, registering an extraordinary CAGR of 84.5% during ...
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the third quarter of 2025 and updated financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback